-
Navigating the US Federal Data Landscape of RWD Availability
Oct 9, 2025, 13:37 PM -
The Value of ECAs for Regulatory and HTA Evidence Needs
Oct 9, 2025, 11:43 AM -
Defining Patient-Centered Access to Improve Health Outcomes
Oct 8, 2025, 13:48 PM -
Novel Study Design to Maximize Patient Follow-Up in Retrospective RWE Research
Oct 1, 2025, 16:48 PM -
Unlocking Success: Overcoming Cell & Gene Therapy Challenges With RWE
Sep 24, 2025, 13:56 PM -
Why Serve on the ISPOR Board? Hear From ISPOR Leaders
Sep 17, 2025, 09:51 AM -
Fit-for-Purpose RWD: An Integral Part of Evidence Planning
Sep 10, 2025, 13:31 PM -
Evolving RWE Standards Under IRA & JCA: Implications for Asia's HTA
Sep 3, 2025, 11:26 AM -
HTA in Pluralistic Healthcare Systems: A Global Perspective
Sep 3, 2025, 11:08 AM -
Using RWE for Label Expansion From The Health System Perspective
Aug 14, 2025, 10:04 AM -
AI in Evidence Synthesis: Are the Robots Taking Over?
Jul 14, 2025, 12:06 PM -
Global Standards, Real-World Impact: The Role of HARPER
Jul 8, 2025, 12:42 PM -
Negative Control Outcomes in Observational Studies of Effectiveness
Jun 18, 2025, 13:39 PM -
Why Elicit Utility Weights For Cost Effectiveness Analysis Using DCEs?
Jun 17, 2025, 11:49 AM -
ISPOR HEOR Competencies: Boosting Career and Networks
Jun 12, 2025, 12:15 PM -
ADHD, GLP-1s, & HIV: Real-World Trends in Prescribing and Adherence
Jun 11, 2025, 14:37 PM -
Causal AI in HEOR: Beyond Predictions to Actionable Insights
Apr 24, 2025, 10:37 AM -
Challenges in Defining Elements of Value in DMD for Decision Making
Mar 25, 2025, 15:33 PM -
Impact of Delayed Patient Access to Cancer Treatment
Mar 18, 2025, 16:26 PM -
Defining Patient-Facing DHIs With the PICOTS-ComTeC Framework
Feb 19, 2025, 10:21 AM